Summary
The basal energy expenditure of 10 Type 1 (insulin-dependent) C-peptide-negative diabetic patients (2042±62 kcal/24 h) was found to be significantly higher than the 1774±52kcal/24h predicted from their age, sex and body surface area (p<0.01). Intravenous insulin treatment significantly reduced energy expenditure to 1728 ±19 kcal/24 h (p< 0.01), which matched predicted values. The observed increase in metabolic rate in uncontrolled diabetic patients is associated with increased protein turnover, increased plasma glucagon, but no significant increase in cortisol, growth hormone or triiodothyronine concentrations in plasma. It may be accounted for by the energy cost of protein synthesis, or gluconeogenesis, or possibly increased sympathetic activity. This increased energy expenditure will contribute to the weight loss seen in Type 1 diabetic patients.
Article PDF
Similar content being viewed by others
References
Pettenkofer M, Voit C (1867) Über den Stoffwechselverbrauch in der Zuckerharnruhr. Zeitschr Biol 3: 380–444
Du Bois EF, Veeder BS (1910) Total energy expenditure in diabetes mellitus. Arch Intern Med 5: 37–46
Van Noorden C (1907) Energy exchange. In: Hall W (ed) Metabolism and practical medicine, Vol III. William Heinemann, London, pp 566–568
Benedict FG, Joslin EP (1910) Metabolism in diabetes mellitus. Carnegie Institution of Washington, Pub No 136:188–234
Lusk G (1911) Metabolism in diabetes mellitus. Science NS 33; 433–434 [a review of Reference 4]
Allen FM, Du Bois EF (1916) Metabolism and treatment in diabetes. Arch Intern Med 16: 1010–1059
Garrow JS, Hawes S (1972) The role of amino acid oxidation in causing specific dynamic action in man. Br J Nutr 27: 211–219
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Christofides ND (1982) Pancreatic glucagon. In: Bloom SR, Ling RG (eds) Radioimmunoassay of gut regulatory peptides. WB Saunders, London, pp 74–79
Boothby WM, Sandiford I (1929) Normal values for standard metabolism. Am J Physiol 90: 290–291
Davidson IWF, Salter JM, Best CH (1960) The effect of glucagon on the metabolic rate of rats. Am J Clin Nutr 8: 540–545
Alberti KGMM, Christensen NJ, Iversen J, Orskov H (1975) Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet 2: 1307–1311
Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D (1983) Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25: 400–403
Nair KS, Ford C, Garrow JS, Halliday D (1983) Effect of insulin therapy on whole body protein turnover in diabetes. Diabetes 32 (Suppl 1): 33P
Payne PR, Waterlow JC (1971) Relative requirements for maintenance, growth and physical activity. Lancet 2: 210–211
Ravussin E, Bogardus C, Schwartz RS, Robbins DC, Wolfe RR, Horton ES, Danforth E Jr., Sims EAH (1983) Thermic effect of infused glucose and insulin in man. J Clin Invest 72: 893–902
Golay A, Schutz Y, Meyer HU, Thieband D, Churchod B, Maeder E, Felber JP, Jequier E (1982) Glucose induced thermogenesis in non-diabetic and diabetic obese subjects. Diabetes 31: 1023–1028
Nair KS, Garrow JS (1984) Increased basal energy expenditure and reduced thermic response in diabetic patients. In: Hordon E, Forth D (eds) Proceedings of Fourth International Congress on Obesity — Satellite meeting on Regulation of Energy Expenditure John Libbey, London (in press)
Nair KS, Halliday D, Garrow JS (1983) Thermic response to isoenergetic protein, carbohydrate or fat meals in lean and obese subjects. Clin Sci 65: 307–312
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nair, K.S., Halliday, D. & Garrow, J.S. Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients. Diabetologia 27, 13–16 (1984). https://doi.org/10.1007/BF00253494
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253494